However, its lack of biologic activity in vivo combined with data generated from siRNA studies downregulating STAT3 expression in sarcoma cell lines strongly suggested that its effects in vitro were not tied to inhibition of STAT3 phosphorylation. The gene discussed is STAT3; the disease is sarcoma.